Category: Recombinants
UK ONS: 2.7% of the British population reporting Long Covid symptoms
An estimated 1.7 million people living in private households in the UK (2.7% of the population) were experiencing self-reported long COVID as of 5 March 2022
The estimates presented in this analysis relate to self-reported long COVID, as experienced by study participants who responded to a representative survey, rather than clinically diagnosed ongoing symptomatic COVID-19 or post-COVID-19 syndrome in the full population. More...
France: XD Deltacron recombinant update
France has issued its latest epidemiological update which gives more details on the growth and characteristics of the XD Deltacron recombinant. More...
UK: XE growth rate now 12.6% higher than BA.2
“Earlier published growth rates for XE were not significantly different from BA.2, but using the most recent data up to 30 March 2022, XE has a growth rate 12.6% above that of BA.2. More...
Preprint: 100% symptomatic infection with XD recombinant
“This recombinant (XD) exhibits immune escape properties similar to Omicron, while its behavior in mice expressing the human ACE2 receptor is more similar to Delta.” More...
Thailand: first cases of XE and XJ recombinants reported
Thailand has reported its first cases of Omicron XE and XJ. More...
Netherlands: BA.1.1/BA.2 recombinant designated XM
A recombinant SARS-CoV-2 variant originally sequenced in the Netherlandshas been designated XM. More...
SARS-CoV-2: New recombinants designated XG, XH, XJ, XK and XL
SARS_CoV-2 recombinants are being designated almost on a daily basis now. More...
UK: XE may have a growth rate ~10% greater than Omicron BA.2 *1 UPDATE*
“Early growth rates for XE were not significantly different from BA.2, but using the most recent data up to 16 March 2022, XE has a growth rate 9.8% above that of BA.2.” More...
France: XD Deltacron recombinant latest *1 UPDATE*
France has given a little more detail about the Deltacron hybrid virus found circulating in various regions there. More...
Deltacron: XD and XF recombinants now ECDC Variants under Monitoring
The European Centre for Disease Prevention and Control (ECDC) have added Deltacron recombinants XD and XF to their list of Variants under Monitoring. More...